Zenith trial result comparison ??

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Zenith trial result comparison ??

posted on Oct 11, 2023 06:43PM

just wondering if Zenith Epigenetics 11 ongoing trials in the several indications have a similar or higher ORR than 30% see the Tempest therapeutics link below

You would think that Zenith would want to release that type of excellent results if they had those results.Tempest Therapeutics released earlier phase 1 results today on their liver cancer drug and saw a 4000% share price increase

https://ca.finance.yahoo.com/news/tempest-releases-data-demonstrating-superiority-120000237.html

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply